Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

Clinical trial NCT00051909 · COMPLETED

Trial details

NCT number: NCT00051909
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2002-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.